Booth Bruce

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$13.49M
Insider Sells Quantity
19
Insider Sells Sum
$124.95M

Insider Activity of Booth Bruce

According to the SEC Form 4 filings, Booth Bruce, being in a position of

  1. director at Kymera Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 961800 shares for $38.34M,
    over all time since 2021-03-12, has bought 0 shares, and sold 2922202 shares for $124.95M.

The largest purchase of all time was on 2022-01-11 and amounted to 535000 shares of Vigil Neuroscience, Inc. for $7.49M.

The largest sale of all time was on 2021-08-11 and amounted to 484266 shares of Kymera Therapeutics, Inc. for $29.54M.

Biography of Booth Bruce

No biography is available at this moment.

2024-07-09SaleKymera Therapeutics, Inc.
KYMR
director
453,960
0.9459%
$38.21$17.35M0%
2024-06-13SaleKymera Therapeutics, Inc.
KYMR
director
10,200
0.0168%
$34.98$356,796+32.28%
2024-06-12SaleKymera Therapeutics, Inc.
KYMR
director
16,740
0.028%
$35.45$593,378+33.18%
2024-03-15SaleKymera Therapeutics, Inc.
KYMR
director
71,764
0.1171%
$40.46$2.9M-0.12%
2024-03-14SaleKymera Therapeutics, Inc.
KYMR
director
55,779
0.0861%
$39.98$2.23M+2.71%
2024-03-13SaleKymera Therapeutics, Inc.
KYMR
director
139,255
0.2271%
$42.23$5.88M-4.45%
2024-03-12SaleKymera Therapeutics, Inc.
KYMR
director
162,918
0.2674%
$41.98$6.84M-3.1%
2024-03-11SaleKymera Therapeutics, Inc.
KYMR
director
51,184
0.0849%
$42.85$2.19M-3.96%
2023-01-12SaleKymera Therapeutics, Inc.
KYMR
director
98,720
0.153%
$30.29$2.99M-26.07%
2023-01-11SaleKymera Therapeutics, Inc.
KYMR
director
27,754
0.0478%
$29.96$831,510-16.97%
2022-12-15SaleKymera Therapeutics, Inc.
KYMR
director
3,278
0.0061%
$30.00$98,340-11.97%
2022-12-14SaleKymera Therapeutics, Inc.
KYMR
director
378,966
0.6933%
$31.37$11.89M-17.08%
2022-11-03SaleKymera Therapeutics, Inc.
KYMR
director
96,397
0.1616%
$30.00$2.89M-11%
2022-11-02SaleKymera Therapeutics, Inc.
KYMR
director
123,619
0.223%
$30.02$3.71M-4.24%
2022-11-01SaleKymera Therapeutics, Inc.
KYMR
director
77,030
0.136%
$30.60$2.36M-7.8%
2022-10-31SaleKymera Therapeutics, Inc.
KYMR
director
120,622
0.2076%
$30.23$3.65M-8.7%
2022-10-28SaleKymera Therapeutics, Inc.
KYMR
director
91,050
0.1573%
$30.00$2.73M-7.5%
2022-01-11PurchaseVigil Neuroscience, Inc.
VIGL
director
535,000
2.3688%
$14.00$7.49M-24.96%
2021-08-11SaleKymera Therapeutics, Inc.
KYMR
director
484,266
1.0271%
$61.00$29.54M-27.25%
2021-03-12SaleKymera Therapeutics, Inc.
KYMR
director
458,700
1.0347%
$56.50$25.92M-6.59%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.